Osimertinib
astrazeneca
[]
great to see this asian female nonsmoker screening study at nyu. n=201 screened. mostly rads1/2. lug. cancer detection rate n=3, 1.5%, all egfr-m+. great to see this is feasible but q is if this screening will improve mortality not survival due to length/lead time bias #asco23 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.